Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Scynexis (SCYX) Research & Development: 2013-2025

Historic Research & Development for Scynexis (SCYX) over the last 13 years, with Sep 2025 value amounting to $5.5 million.

  • Scynexis' Research & Development fell 32.47% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year decrease of 32.53%. This contributed to the annual value of $26.4 million for FY2024, which is 14.62% down from last year.
  • Per Scynexis' latest filing, its Research & Development stood at $5.5 million for Q3 2025, which was down 23.65% from $7.1 million recorded in Q2 2025.
  • Scynexis' Research & Development's 5-year high stood at $10.6 million during Q4 2023, with a 5-year trough of $4.3 million in Q4 2024.
  • For the 3-year period, Scynexis' Research & Development averaged around $6.8 million, with its median value being $6.8 million (2023).
  • As far as peak fluctuations go, Scynexis' Research & Development soared by 50.63% in 2022, and later plummeted by 59.25% in 2024.
  • Scynexis' Research & Development (MRQ) stood at $7.7 million in 2021, then rose by 2.07% to $7.8 million in 2022, then skyrocketed by 34.87% to $10.6 million in 2023, then plummeted by 59.25% to $4.3 million in 2024, then grew by 26.38% to $5.5 million in 2025.
  • Its Research & Development stands at $5.5 million for Q3 2025, versus $7.1 million for Q2 2025 and $5.1 million for Q1 2025.